🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT03579901
Active, not recruiting Not applicable

Study of the Safety and Effectiveness of Motiva Implants®

NCT03579901 · tracked via the Priya Life Science USA tracker
Sponsor
Motiva USA LLC
Phase
Not applicable
Started
2018-04-06
Last updated
2025-11-12

Condition(s) studied

Breast Implants

Investigational drug(s) / intervention(s)

Silicone gel-filled breast implants - Motiva Implants® Investigational breast implants

Silicone gel-filled breast implants - Motiva Implants® Investigational breast implants: Breast augmentation

Study summary

This study evaluates the safety and effectiveness Motiva Implants® in women who are undergoing primary breast augmentation, primary breast reconstruction or revision breast surgery.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
70 Years
Healthy volunteers
Accepted
Inclusion Criteria * Genetic female. * Patient is seeking one of the following procedures: Primary Breast Augmentation Primary Breast Reconstruction Revision Augmentation Revision Reconstruction * Patient has adequate tissue available to cover implant(s). * Willingness to follow all study requirements including agreeing to attend all required follow-up visits and signs the informed consent. * Agrees to have device returned to Establishment Labs if explanted. * Willing to undergo Magnetic Resonance Imaging (MRI) evaluation of medically advised. Exclusion Criteria: * Has any breast disease considered to be pre-malignant in one or both breasts or is reporting mutations in BRCA1 or BRCA2 without a previous bilateral mastectomy or an untreated cancer of any type. * Has inadequate or unsuitable tissue (e.g., due to radiation damage, ulceration compromised vascularity, history of compromised wound healing). * Has an abscess or infection. * Is pregnant or nursing or has had a full-term pregnancy or lactated within 6 months of enrollment. * Is taking any drugs that would interfere with blood clotting, or that might result in elevated risk and or significant postoperative complications. * Has any medical condition such as obesity (BMI ≥ 40), diabetes, autoimmune disease, chronic lung or severe cardiovascular disease that might result in unduly high surgical risk and or significant postoperative complications. * Has any connective tissue/autoimmune disorder or rheumatoid disease, such as systemic lupus erythematosus, discoid lupus, scleroderma, or rheumatoid arthritis, among others. * Has any condition that impedes the use of magnetic resonance imaging (MRI) including implanted metal device, claustrophobia or other conditions that would make MRI scan prohibited. * Has a history of psychological characteristics that are unrealistic or unreasonable given the risks involved with the surgical procedure. * Has been implanted with any non-FDA approved breast implant. * Has been implanted with any silicone implant other than breast implants. * HIV positive (based on medical history). * Has been diagnosed with anaplastic large cell lymphoma (ALCL). * Works for Establishment Labs, Motiva USA or any of their subsidiaries, the study surgeon, or ICON the Contract Research Organization (CRO) that is helping to conduct the study or are directly-related to anyone that works for Establishment Labs, Motiva USA or any of their subsidiaries, the study surgeon, or the CRO.

Primary outcome measure(s)

Trial sites (29)

FacilityCityRegionStatus
Gerald Minitti, MD, FACS Beverly Hills California
Steven Teitelbaum, MD, FACS Santa Monica California
Westlake Cosmetic Surgery Center Westlake Village California
The Center for Cosmetic Surgery Golden Colorado
Emory University Hospital Atlanta Georgia
Northwestern Plastic Surgery Chicago Illinois
Northwestern Specialists in Plastic Surgery, S.C. Chicago Illinois
Meridian Plastic Surgery Center Indianapolis Indiana
CaloAesthetics® Plastic Surgery Center Louisville Kentucky
The Wall Center for Plastic Surgery Shreveport Louisiana
Partners in Plastic Surgery of West Michigan Grand Rapids Michigan
Parkcrest Plastic Surgery St Louis Missouri
Glicksman Plastic Surgery Sea Girt New Jersey
Mark D. Epstein, MD, FACS/ Center for Aesthetic Surgery Hauppauge New York
NYU Plastic Surgery Associates New York New York
May Center for Mount Sinai Doctors New York New York
Fifth Avenue Millennium Aesthetic Surgery, PLLC New York New York
Cleveland Clinic Main Campus Cleveland Ohio
Movassaghi Plastic Surgery & Ziba Medical Spa Eugene Oregon
Portland Plastic Surgery Portland Oregon
Body by Z Providence Rhode Island
Maxwell Aesthetics, PLLC Nashville Tennessee
Strock Plastic Surgery Fort Worth Texas
Houston Methodist Houston Texas
MD Anderson Cancer Center Houston Texas
William P. Adams Plastic Surgery University Park Texas
PeaceHealth Plastic Surgery Vancouver Washington
Plastische Chirurgie im Medienhafen Düsseldorf Germany
Victoriakliniken Stockholm Sweden

More Motiva USA LLC trials in the USA

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03579901 on ClinicalTrials.gov ↗ ← All trials in the USA